Detalles de la búsqueda
1.
ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer.
BMC Cancer;
24(1): 330, 2024 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38468232
2.
PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation.
BMC Cancer;
23(1): 573, 2023 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37349676
3.
miRNA-651-3p regulates EMT in ovarian cancer cells by targeting ZNF703 and via the MEK/ERK pathway.
Biochem Biophys Res Commun;
619: 76-83, 2022 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35749939
4.
HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways.
BMC Cancer;
22(1): 1338, 2022 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36544104
5.
Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer.
BMC Cancer;
22(1): 690, 2022 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35739489
6.
Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer.
Genomics;
113(4): 2134-2144, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33845140
7.
Identification of the prognostic value of a 2-gene signature of the WNT gene family in UCEC using bioinformatics and real-world data.
Cancer Cell Int;
21(1): 516, 2021 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34565373
8.
YWHAE as an HE4 interacting protein can influence the malignant behaviour of ovarian cancer by regulating the PI3K/AKT and MAPK pathways.
Cancer Cell Int;
21(1): 302, 2021 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34107979
9.
Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma.
J Cell Mol Med;
24(5): 2819-2831, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31995855
10.
Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing.
Oxid Med Cell Longev;
2023: 1261039, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36743693
11.
Prognostic biomarker MCP-4 triggers epithelial-mesenchymal transition via the p38 MAPK pathway in ovarian cancer.
Front Oncol;
12: 1034737, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36531002
12.
RAD21 Confers Poor Prognosis and Affects Ovarian Cancer Sensitivity to Poly(ADP-Ribose)Polymerase Inhibitors Through DNA Damage Repair.
Front Oncol;
12: 936550, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35860572
13.
Prognostic value of immune-related cells and genes in the tumor microenvironment of ovarian cancer, especially CST4.
Life Sci;
277: 119461, 2021 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33811900
14.
Keratin 80 regulated by miR-206/ETS1 promotes tumor progression via the MEK/ERK pathway in ovarian cancer.
J Cancer;
12(22): 6835-6850, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34659572
15.
PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes.
Front Oncol;
11: 682461, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34277429
16.
Identification of KIF23 as a prognostic signature for ovarian cancer based on large-scale sampling and clinical validation.
Am J Transl Res;
12(9): 4955-4976, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33042400
17.
ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15.
J Exp Clin Cancer Res;
39(1): 264, 2020 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33246486
Resultados
1 -
17
de 17
1
Próxima >
>>